{"id":"W2108598528","doi":"10.1016/j.currproblcancer.2009.10.002","title":"Epidermal Growth Factor Receptor Inhibitors: Current Status and Future Directions","year":2009,"lang":"en","type":"review","venue":"Current Problems in Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Gefitinib; In vivo; Epidermal growth factor receptor; Medicine; Apoptosis; Pharmacology; Lapatinib; IC50; In vitro; Epidermal growth factor; Prodrug; Growth inhibition; Receptor; Cancer research; Biochemistry; Cancer; Internal medicine; Chemistry; Biology; Trastuzumab; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008623236,0.0006450602,0.001553524,0.0004538761,0.0001248806,0.00006085318,0.00009760802,0.0002581491,0.0002759462],"category_scores_gemma":[0.00003047568,0.0004768639,0.0003429534,0.0006819577,0.00008067344,0.0001890757,0.00005756001,0.001033939,0.00002669538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001642381,"about_ca_system_score_gemma":0.001401074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001414523,"about_ca_topic_score_gemma":0.00009572206,"domain_scores_codex":[0.997321,0.0001078729,0.0008502758,0.0007900858,0.0003197188,0.0006110615],"domain_scores_gemma":[0.9987291,0.0000674408,0.0003870086,0.0003153609,0.0001467442,0.0003544205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004876148,0.000400484,0.0008452677,0.0158328,0.0001788666,0.00000190904,0.0004174378,3.324485e-7,1.515798e-7,0.00006742449,0.004783707,0.9774668],"study_design_scores_gemma":[0.0009263738,0.0001070109,0.0005454337,0.03511276,0.001314449,0.00001118354,0.00001417912,8.720379e-7,5.727559e-7,0.00005688081,0.9614911,0.0004191458],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002988096,0.9899466,0.000005108813,0.0003426199,0.005853697,0.002703538,0.0007391651,0.00009768778,0.0002816738],"genre_scores_gemma":[0.000014234,0.9939095,0.00006886526,0.00002548032,0.003234724,0.001784898,0.0007196979,0.00007374851,0.0001688279],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9770476,"threshold_uncertainty_score":0.9997683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05871859868774859,"score_gpt":0.4105521500524492,"score_spread":0.3518335513647006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}